| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.95B | 5.40B | 4.96B | 4.50B | 7.46B | 8.65B |
| Gross Profit | 5.95B | 5.40B | 4.96B | 6.88B | 6.01B | 8.65B |
| EBITDA | 2.35B | 2.93B | 2.00B | 2.41B | 2.51B | 2.28B |
| Net Income | 1.97B | 1.67B | 1.59B | 1.22B | 1.31B | 1.16B |
Balance Sheet | ||||||
| Total Assets | 271.81B | 266.52B | 269.79B | 259.85B | 256.53B | 254.96B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 15.67B | 21.02B | 21.43B | 16.85B | 19.93B |
| Total Debt | 4.27B | 4.15B | 8.89B | 8.45B | 4.13B | 8.02B |
| Total Liabilities | 226.62B | 223.33B | 228.79B | 222.69B | 218.70B | 219.27B |
| Stockholders Equity | 36.29B | 34.64B | 32.68B | 29.52B | 30.19B | 28.39B |
Cash Flow | ||||||
| Free Cash Flow | 4.51B | 4.05B | -2.10B | 5.36B | 3.69B | -7.52B |
| Operating Cash Flow | 4.92B | 4.40B | -2.10B | 5.54B | 3.93B | -7.38B |
| Investing Cash Flow | 25.82M | -43.53M | -44.88M | -38.60M | -93.54M | 2.65M |
| Financing Cash Flow | -7.91B | -7.98B | 962.65M | 2.95B | 1.19B | 7.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.15T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
74 Outperform | HK$12.92B | 1.96 | 5.55% | 6.53% | -1.78% | 10.62% | |
71 Outperform | HK$456.53B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$17.46B | 2.17 | 6.51% | 6.54% | ― | ― | |
66 Neutral | HK$501.60B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
64 Neutral | HK$35.58B | 10.03 | 3.26% | 5.78% | -7.68% | 49.57% |